相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。AT7519, a Cyclin-Dependent Kinase Inhibitor, Exerts Its Effects by Transcriptional Inhibition in Leukemia Cell Lines and Patient Samples
Matthew S. Squires et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Biological characterization of AT7519, a small-molecule inhibitor of cyclin-dependent kinases, in human tumor cell lines
Matthew S. Squires et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug design
Paul G. Wyatt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
CDK inhibitors in cancer therapy: what is next?
Marcos Malumbres et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Targeting the cell cycle: A new approach to cancer therapy
GK Schwartz et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Recent advances in the development of selective small molecule inhibitors for cyclin-dependent kinases
H Hirai et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2005)
High-throughput crystallography for lead discovery in drug design
TL Blundell et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
To cycle or not to cycle: A critical decision in cancer
M Malumbres et al.
NATURE REVIEWS CANCER (2001)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
